Pulmonary artery combined with right heart failure.

High pulmonary artery combined right heart failure is a serious clinical condition that requires a comprehensive diagnostic strategy to manage. The following are detailed recommendations for the treatment of the disease:I. DiagnosisClinical performance:Patients may have symptoms such as short-respiration, susceptibility to fatigue, fainting, chest pain, and oedema in legs and ankles.The heart can be smelled and the P2 swelled.Auxiliary examination:EKG: May show right heart chamber fat or heart disorder.Hyperheartmatric: Assessing changes in the structure and function of the heart, especially in the right heart.Right-heart catheter examination: The direct measurement of lung artery pressure and heart output is the gold standard for the diagnosis of pulmonary artery high pressure.Breast X-ray and CT: Observation of morphological changes in lungs and heart.TreatmentThe treatment of high pulmonary artery combined with right heart failure requires individualized treatment that takes into account the patient ‘ s specific condition.General treatment:Control of liquid retention and restriction of sodium salt intake.Weight monitoring and the careful use of urinants such as hydrochloride and fursemic, etc., with care to monitor potassium blood to avoid low potassium haematosis.Avoiding triggers such as infection, heat, labour, emotion, etc.(c) To adjust the way of life, to stop smoking and drinking, to maintain the right exercise, to rationalize the time available and to maintain a calm mind.Patient treatment:Actively treating basic lung diseases, such as COPD, inter-pulmonary diseases, bronchial asthma, etc., which may increase the right-heart load due to reduced lung function.Treatment of potential causes such as cardiac valve disease and cardiac disease may require surgical repair or replacement of valves, medication, etc.2. Drug treatment:Urine: ablution of liquid retention and oedema symptoms.Angiogens: e.g. nitrate-type drugs, phentolamine, etc., can expand the veins and reduce the heart load.Positive muscular drugs: DPT, for example, increases myocardial condensation, and is one of the first drugs to treat pulmonary arterial high pressure combined with right heart failure.Oceanic yellow drugs: e.g., geocoxin can enhance myocardial constriction, but care needs to be taken that people with oxygen deficiency and low blood potassium are vulnerable to oceanic yellow poisoning.Other drugs, including vascular stressor enzyme inhibitors, vascular stressor receptors, beta receptor retardants, etc., can improve the heart function and reduce the heart load.3. Long-term oxygen therapy:For patients with blood oxygen saturation of less than 90 per cent, it is recommended that routine oxygen therapy be used to improve the oxygen deficiency of vital body organs.Long-term oxygen therapy can correct low oxygen haematosis, relieve pulmonary arterytic convulsions caused by oxygen deficiency and reduce lung artery pressure.Surgery:In cases where other treatments are ineffective, surgical treatment may be considered.Cardiac or pulmonary transplants may be an effective treatment for patients with severe and ineffective conservative treatment.For patients with cardiac disorders, the use of pacemaker or heart defibrillator can be considered to help restore normal heart.New treatment methods:As medicine advances, new treatments, such as gene transfer techniques, anti-reflective technologies, are being studied and may provide new tools for the treatment of right-cardiac failure combined with pulmonary arterial hypertension.III. FOLLOW-UP AND MONITORINGPatients are required to make regular visits to monitor changes in conditions.The treatment programme is adjusted in a timely manner in the light of changes in conditions.Attention to the monitoring of drug side effects and interactions, and to avoid self-infliction and reduction of drug doses or withdrawals.In the light of the above, the combination of pulmonary artery and right heart failure requires a combination of patient-specific conditions and individualized treatment. Active treatment and follow-up monitoring can significantly improve patients ‘ symptoms and quality of life.